相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。89Zr-PET Radiochemistry in the Development and Application of Therapeutic Monoclonal Antibodies and Other Biologicals
Danielle J. Vugts et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2013)
Targeting chronic lymphocytic leukemia cells with a humanized monoclonal antibody specific for CD44
Suping Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Global Quantitative Phosphoproteome Analysis of Human Tumor Xenografts Treated with a CD44 Antagonist
Stefan Weigand et al.
CANCER RESEARCH (2012)
PET and MRI of Metastatic Peritoneal and Pulmonary Colorectal Cancer in Mice with Human Epidermal Growth Factor Receptor 1-Targeted Zr-89-Labeled Panitumumab
Tapan K. Nayak et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
Physiological Contribution of CD44 as a Ligand for E-Selectin during Inflammatory T-Cell Recruitment
Maria Nacher et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Immuno-Positron Emission Tomography: Shedding Light on Clinical Antibody Therapy
Guus A. M. S. van Dongen et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2010)
Biodistribution of 89Zr-trastuzumab and PET Imaging of HER2-Positive Lesions in Patients With Metastatic Breast Cancer
E. C. Dijkers et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
Radioimmunoimaging with Longer-Lived Positron-Emitting Radionuclides: Potentials and Challenges
Tapan K. Nayak et al.
BIOCONJUGATE CHEMISTRY (2009)
Phase I Biodistribution and Pharmacokinetic Study of Lewis Y-Targeting Immunoconjugate CMD-193 in Patients with Advanced Epithelial Cancers
Rebecca A. Herbertson et al.
CLINICAL CANCER RESEARCH (2009)
Preclinical evaluation of carcinoembryonic cell adhesion molecule (CEACAM) 6 as potential therapy target for pancreatic adenocarcinoma
Laura A. Strickland et al.
JOURNAL OF PATHOLOGY (2009)
Involvement of CD44, a molecule with a thousand faces, in cancer dissemination
David Naor et al.
SEMINARS IN CANCER BIOLOGY (2008)
A phase I dose escalation study with anti-CD44v6 bivatuzumab mertansine in patients with incurable squamous cell carcinoma of the head and neck or esophagus
Bernard M. Tijink et al.
CLINICAL CANCER RESEARCH (2006)
Performance of immuno-positron emission tomography with zirconium-89-labeled chimeric monoclonal antibody U36 in the detection of lymph node metastases in head and neck cancer patients
PKE Börjesson et al.
CLINICAL CANCER RESEARCH (2006)
The effect of anti-CD44 monoclonal antibodies on differentiation and proliferation of human acute myeloid leukemia cells
Z Gadhoum et al.
LEUKEMIA & LYMPHOMA (2004)
Safety, biodistribution, pharmacokinetics, and immunogenicity of 99mTc-labeled humanized monoclonal antibody BIWA 4 (bivatuzumab) in patients with squamous cell carcinoma of the head and neck
DR Colnot et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2003)
CD44: From adhesion molecules to signalling regulators
H Ponta et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2003)
分享论文
